Contrast agent developer E-Z-EM reported record sales of $133.2 million in fiscal 2003, up 9% compared with the $122.1 million booked in fiscal 2002. For the fiscal year (end-May 31), the Lake Success, NY-based firm had net earnings of $2.7 million, compared with net earnings of $585,000 last year.
In the fourth quarter, E-Z-EM's net sales were $36.9 million, up 11% compared with $33.2 million last year. The vendor had net earnings of $2.2 million for the period, compared with net earnings of $707,000 in the fourth quarter of 2002.
E-Z-EM attributed the gains to continued growth in its AngioDynamics subsidiary and to strong sales of its CT diagnostic products. At AngioDynamics, sales grew 34% in the fourth quarter and 24% in fiscal 2003, while E-Z-EM’s core segment turned in 3% quarterly sales growth and 4% for the year. The company said that its balance sheet and financial position remain strong.
By AuntMinnie.com staff writersAugust 13, 2003
Related Reading
E-Z-EM, Berlex to partner, July 15, 2003
E-Z-EM to close New York and Puerto Rico operations, June 2, 2003
E-Z-EM, 3CPM sign agreement, April 17, 2003
E-Z-EM shows sales growth in Q3, April 15, 2003
E-Z-EM and JPC ink multiyear deal, April 10, 2003
Copyright © 2003 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
